Renato Bassan

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 39

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Practice

Prognostic Factors

Acute Lymphoblastic Leukemia

Top Venues

Leukemia & lymphoma

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Herve Dombret, Michael Doubek, Adele K Fielding, Robin Foà, Sebastian Giebel, Dieter Hoelzer, Mathilde M Hunault-Berger, David I Marks, Giovanni Martinelli, Oliver Gerhard Ottmann, Anita W Rijneveld, Philippe Rousselot, Josep-María Ribera, Renato Bassan
Diagnosis, Prognostic Factors and Assessment of ALL in Adults: 2023 ELN Recommendations from a European Expert Panel. Blood (2024)
Amir Enshaei, Melvin Joy, Ellie Butler, Amy A Kirkwood, Monica Messina, Chiara Pavoni, Mireia Morgades, Christine J Harrison, Robin Foà, Josep-María Ribera, Sabina Chiaretti, Renato Bassan, Adele K Fielding, Anthony V Moorman
A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study. Blood advances 8 (5) (2024)
Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Hervé Dombret, Michael Doubek, Adele K Fielding, Robin Foà, Sebastian Giebel, Dieter Hoelzer, Mathilde M Hunault-Berger, David I Marks, Giovanni Martinelli, Oliver Ottmann, Anita Rijneveld, Philippe Rousselot, Josep-María Ribera, Renato Bassan
Management of ALL in adults: 2024 ELN recommendations from a European expert panel. Blood 143 (19) (2024)
Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Hervé Dombret, Michael Doubek, Adele K Fielding, Robin Foà, Sebastian Giebel, Dieter Hoelzer, Mathilde M Hunault-Berger, David I Marks, Giovanni Martinelli, Oliver Gerhard Ottmann, Anita Rijneveld, Philippe Rousselot, Josep-María Ribera, Renato Bassan
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel. Blood 143 (19) (2024)
Amir Enshaei, Melvin Joy, Ellie Butler, Amy A Kirkwood, Monica Messina, Chiara Pavoni, Mireia Morgades, Christine J Harrison, Robin Foà, Josep-María Ribera, Sabina Chiaretti, Renato Bassan, Adele K Fielding, Anthony V Moorman
A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study. Blood advances 8 (5) (2024)
Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Herve Dombret, Michael Doubek, Adele K Fielding, Robin Foà, Sebastian Giebel, Dieter Hoelzer, Mathilde M Hunault-Berger, David I Marks, Giovanni Martinelli, Oliver Gerhard Ottmann, Anita W Rijneveld, Philippe Rousselot, Josep-María Ribera, Renato Bassan
Diagnosis, Prognostic Factors and Assessment of ALL in Adults: 2023 ELN Recommendations from a European Expert Panel. Blood (2024)
Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Herve Dombret, Michael Doubek, Adele K Fielding, Robin Foà, Sebastian Giebel, Dieter Hoelzer, Mathilde M Hunault-Berger, David I Marks, Giovanni Martinelli, Oliver Ottmann, Anita W Rijneveld, Philippe Rousselot, Josep-María Ribera, Renato Bassan
Management of ALL in Adults: 2023 ELN Recommendations from a European Expert Panel. Blood (2024)
Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Herve Dombret, Michael Doubek, Adele K Fielding, Robin Foà, Sebastian Giebel, Dieter Hoelzer, Mathilde M Hunault-Berger, David I Marks, Giovanni Martinelli, Oliver Ottmann, Anita W Rijneveld, Philippe Rousselot, Josep-María Ribera, Renato Bassan
Management of ALL in Adults: 2023 ELN Recommendations from a European Expert Panel. Blood (2024)
Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Hervé Dombret, Michael Doubek, Adele K Fielding, Robin Foà, Sebastian Giebel, Dieter Hoelzer, Mathilde M Hunault-Berger, David I Marks, Giovanni Martinelli, Oliver Ottmann, Anita Rijneveld, Philippe Rousselot, Josep-María Ribera, Renato Bassan
Management of ALL in adults: 2024 ELN recommendations from a European expert panel. Blood 143 (19) (2024)
Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Hervé Dombret, Michael Doubek, Adele K Fielding, Robin Foà, Sebastian Giebel, Dieter Hoelzer, Mathilde M Hunault-Berger, David I Marks, Giovanni Martinelli, Oliver Gerhard Ottmann, Anita Rijneveld, Philippe Rousselot, Josep-María Ribera, Renato Bassan
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel. Blood 143 (19) (2024)
Franco Locatelli, Bijal Shah, Tracy Thomas, Kelly Velasco, Babatunde Adedokun, Ibrahim Aldoss, Lia Gore, Dieter Hoelzer, Renato Bassan, Jae H Park, Nicolas Boissel, Hagop M Kantarjian
Incidence of CD19-negative relapse after CD19-targeted immunotherapy in R/R BCP acute lymphoblastic leukemia: a review. Leukemia & lymphoma (2023)
Amir Enshaei, Melvin Joy, Ellie R Butler, Amy A Kirkwood, Monica Messina, Chiara Pavoni, Mireia Morgades, Christine J Harrison, Robin Foà, Josep-María Ribera, Sabina Chiaretti, Renato Bassan, Adele K Fielding, Anthony V Moorman
A robust and validated integrated prognostic index for defining risk groups in adult ALL: A EWALL collaborative study. Blood advances (2023)
Caterina Ilari, Renato Bassan, Loredana Elia, Alfonso Piciocchi, Stefano Soddu, Monica Messina, Felicetto Ferrara, Monia Lunghi, Antonino Mulè, Massimiliano Bonifacio, Nicola Stefano Fracchiolla, Prassede Salutari, Paola Fazi, Anna Guarini, Alessandro Rambaldi, Sabina Chiaretti
Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (8) (2023)
Caterina Ilari, Renato Bassan, Loredana Elia, Alfonso Piciocchi, Stefano Soddu, Monica Messina, Felicetto Ferrara, Monia Lunghi, Antonino Mulè, Massimiliano Bonifacio, Nicola Stefano Fracchiolla, Prassede Salutari, Paola Fazi, Anna Guarini, Alessandro Rambaldi, Sabina Chiaretti
Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (8) (2023)
Nicolas Boissel, Sabina Chiaretti, Cristina Papayannidis, Josep-María Ribera, Renato Bassan, Andrey N Sokolov, Naufil Alam, Alessandra Brescianini, Isabella Pezzani, Georg Kreuzbauer, Gerhard Zugmaier, Robin Foà, Alessandro Rambaldi
Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study. Blood cancer journal 13 (1) (2023)
Nicolas Boissel, Sabina Chiaretti, Cristina Papayannidis, Josep-María Ribera, Renato Bassan, Andrey N Sokolov, Naufil Alam, Alessandra Brescianini, Isabella Pezzani, Georg Kreuzbauer, Gerhard Zugmaier, Robin Foà, Alessandro Rambaldi
Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study. Blood cancer journal 13 (1) (2023)
Caterina Ilari, Renato Bassan, Loredana Elia, Alfonso Piciocchi, Stefano Soddu, Monica Messina, Felicetto Ferrara, Monia Lunghi, Antonino Mulè, Massimiliano Bonifacio, Nicola Stefano Fracchiolla, Prassede Salutari, Paola Fazi, Anna Guarini, Alessandro Rambaldi, Sabina Chiaretti
Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (8) (2023)
Caterina Ilari, Renato Bassan, Loredana Elia, Alfonso Piciocchi, Stefano Soddu, Monica Messina, Felicetto Ferrara, Monia Lunghi, Antonino Mulè, Massimiliano Bonifacio, Nicola Stefano Fracchiolla, Prassede Salutari, Paola Fazi, Anna Guarini, Alessandro Rambaldi, Sabina Chiaretti
Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (8) (2023)
Renato Bassan, Sabina Chiaretti, Irene Della Starza, Orietta Spinelli, Alessandra Santoro, Francesca Paola Paoloni, Monica Messina, Loredana Elia, Maria Stefania Stefania De Propris, Anna Maria Scattolin, Ernesta Audisio, Laura Marbello, Erika Borlenghi, Patrizia Zappasodi, Elisa Mauro, Giovanni Martinelli, Daniele Mattei, Nicola Stefano Fracchiolla, Monica Bocchia, Paolo De Fabritiis, Massimiliano Bonifacio, Anna Candoni, Vincenzo Cassibba, Paolo Di Bartolomeo, Giancarlo Latte, Silvia Trappolini, Anna Rita Guarini, Antonella Vitale, Paola Fazi, Alfonso Piciocchi, Alessandro Rambaldi, Robin Foà
Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial. Blood advances (2023)
Caterina Ilari, Renato Bassan, Loredana Elia, Alfonso Piciocchi, Stefano Soddu, Monica Messina, Felicetto Ferrara, Monia Lunghi, Antonino Mulè, Massimiliano Bonifacio, Nicola Stefano Fracchiolla, Prassede Salutari, Paola Fazi, Anna Guarini, Alessandro Rambaldi, Sabina Chiaretti
Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Nicolas Boissel, Sabina Chiaretti, Cristina Papayannidis, Josep-María Ribera, Renato Bassan, Andrey N Sokolov, Naufil Alam, Alessandra Brescianini, Isabella Pezzani, Georg Kreuzbauer, Gerhard Zugmaier, Robin Foà, Alessandro Rambaldi
Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study. Blood cancer journal 13 (1) (2023)
Nicolas Boissel, Sabina Chiaretti, Cristina Papayannidis, Josep-María Ribera, Renato Bassan, Andrey N Sokolov, Naufil Alam, Alessandra Brescianini, Isabella Pezzani, Georg Kreuzbauer, Gerhard Zugmaier, Robin Foà, Alessandro Rambaldi
Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study. Blood cancer journal 13 (1) (2023)
Deborah Cardinali, Marco Beldinanzi, Michela Ansuinelli, Loredana Elia, Irene Della Starza, Vittorio Bellomarino, Mabel Matarazzo, Mariangela Di Trani, Mattia Cola, Prassede Salutari, Michele Cedrone, Renato Bassan, Marco De Gobbi, Matteo Giovanni Della Porta, Mariacarla De Simone, Caterina Alati, Nicola Stefano Fracchiolla, Monia Lunghi, Tamara Intermesoli, Valeria Cardinali, Antonino Mulè, Anna Guarini, Robin Foà, Sabina Chiaretti
Digital droplet PCR for T315I BCR::ABL1 KD mutation assessment in adult Ph-positive acute lymphoblastic leukemia with a minimal residual disease increase. Leukemia & lymphoma (2023)
Sabina Chiaretti, Akram Taherinasab, Irene Della Starza, Martina Canichella, Michela Ansuinelli, Maria Stefania De Propris, Monica Messina, Orietta Spinelli, Alessandra Santoro, Lucia Anna De Novi, Deborah Cardinali, Mattia Schipani, Valentina Arena, Renato Bassan, Anna Guarini, Robin Foà
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings. Leukemia & lymphoma 64 (2) (2022)
Sabina Chiaretti, Akram Taherinasab, Irene Della Starza, Martina Canichella, Michela Ansuinelli, Maria Stefania De Propris, Monica Messina, Orietta Spinelli, Alessandra Santoro, Lucia Anna De Novi, Deborah Cardinali, Mattia Schipani, Valentina Arena, Renato Bassan, Anna Guarini, Robin Foà
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings. Leukemia & lymphoma (2022)
Sabina Chiaretti, Akram Taherinasab, Irene Della Starza, Martina Canichella, Michela Ansuinelli, Maria Stefania De Propris, Monica Messina, Orietta Spinelli, Alessandra Santoro, Lucia Anna De Novi, Deborah Cardinali, Mattia Schipani, Valentina Arena, Renato Bassan, Anna Guarini, Robin Foà
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings. Leukemia & lymphoma 64 (2) (2022)
Sabina Chiaretti, Akram Taherinasab, Irene Della Starza, Martina Canichella, Michela Ansuinelli, Maria Stefania De Propris, Monica Messina, Orietta Spinelli, Alessandra Santoro, Lucia Anna De Novi, Deborah Cardinali, Mattia Schipani, Valentina Arena, Renato Bassan, Anna Guarini, Robin Foà
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings. Leukemia & lymphoma 64 (2) (2022)
Sabina Chiaretti, Akram Taherinasab, Irene Della Starza, Martina Canichella, Michela Ansuinelli, Maria Stefania De Propris, Monica Messina, Orietta Spinelli, Alessandra Santoro, Lucia Anna De Novi, Deborah Cardinali, Mattia Schipani, Valentina Arena, Renato Bassan, Anna Guarini, Robin Foà
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings. Leukemia & lymphoma 64 (2) (2022)
Sabina Chiaretti, Akram Taherinasab, Irene Della Starza, Martina Canichella, Michela Ansuinelli, Maria Stefania De Propris, Monica Messina, Orietta Spinelli, Alessandra Santoro, Lucia Anna De Novi, Deborah Cardinali, Mattia Schipani, Valentina Arena, Renato Bassan, Anna Guarini, Robin Foà
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings. Leukemia & lymphoma 64 (2) (2022)
Sabina Chiaretti, Akram Taherinasab, Irene Della Starza, Martina Canichella, Michela Ansuinelli, Maria Stefania De Propris, Monica Messina, Orietta Spinelli, Alessandra Santoro, Lucia Anna De Novi, Deborah Cardinali, Mattia Schipani, Valentina Arena, Renato Bassan, Anna Guarini, Robin Foà
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings. Leukemia & lymphoma 64 (2) (2022)
Alfonso Piciocchi, Monica Messina, Loredana Elia, Antonella Vitale, Stefano Soddu, Anna Maria Testi, Sabina Chiaretti, Marco Mancini, Francesco Albano, Antonio Spadano, Mauro Krampera, Massimiliano Bonifacio, Roberto Cairoli, Calogero Vetro, Florinda Colella, Felicetto Ferrara, Giuseppe Cimino, Renato Bassan, Paola Fazi, Marco Vignetti
Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996. American journal of hematology 96 (9) (2021)
Manuela Tosi, Orietta Spinelli, Matteo Leoncin, Roberta Cavagna, Chiara Pavoni, Federico Lussana, Tamara Intermesoli, Luca Frison, Giulia Perali, Francesca Carobolante, Piera Viero, Cristina Skert, Alessandro Rambaldi, Renato Bassan
MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL. Cancers 13 (9) (2021)
Renato Bassan, Tamara Intermesoli, Arianna Masciulli, Chiara Pavoni, Cristina Boschini, Giacomo Gianfaldoni, Filippo Marmont, Irene Cavattoni, Daniele Mattei, Elisabetta Terruzzi, Lorella De Paoli, Chiara Cattaneo, Erika Borlenghi, Fabio Ciceri, Massimo Bernardi, Anna M Scattolin, Elisabetta Todisco, Leonardo Campiotti, Paolo Corradini, Agostino Cortelezzi, Dario Ferrero, Pamela Zanghì, Elena Oldani, Orietta Spinelli, Ernesta Audisio, Sergio Cortelazzo, Alberto Bosi, Brunangelo Falini, Enrico M Pogliani, Alessandro Rambaldi
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML. Blood advances 3 (7) (2020)
Francesca Carobolante, Sabina Chiaretti, Cristina Skert, Renato Bassan
Practical guidance for the management of acute lymphoblastic leukemia in the adolescent and young adult population. Therapeutic advances in hematology 11 (2020)
Silvia Salmoiraghi, Roberta Cavagna, Pamela Zanghì, Chiara Pavoni, Anna Michelato, Ksenija Buklijas, Lara Elidi, Tamara Intermesoli, Federico Lussana, Elena Oldani, Chiara Caprioli, Paola Stefanoni, Giacomo Gianfaldoni, Ernesta Audisio, Elisabetta Terruzzi, Lorella De Paoli, Erika Borlenghi, Irene Cavattoni, Daniele Mattei, Annamaria Scattolin, Monica Tajana, Fabio Ciceri, Elisabetta Todisco, Leonardo Campiotti, Paolo Corradini, Nicola Fracchiolla, Renato Bassan, Alessandro Rambaldi, Orietta Spinelli
High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG). Cancers 12 (8) (2020)
Francesco Mannelli, Giacomo Gianfaldoni, Sara Bencini, Matteo Piccini, Ilaria Cutini, Maria Ida Bonetti, Barbara Scappini, Fabiana Pancani, Vanessa Ponziani, Marco Chiarini, Erika Borlenghi, Renato Bassan, Giuseppe Rossi, Alberto Bosi
Early peripheral blast cell clearance predicts minimal residual disease status and refines disease prognosis in acute myeloid leukemia. American journal of hematology 95 (11) (2020)
Silvia Salmoiraghi, Roberta Cavagna, Marie Lorena Guinea Montalvo, Greta Ubiali, Manuela Tosi, Barbara Peruta, Tamara Intermesoli, Elena Oldani, Anna Salvi, Chiara Pavoni, Ursula Giussani, Renato Bassan, Alessandro Rambaldi, Orietta Spinelli
Immature Immunoglobulin Gene Rearrangements Are Recurrent in B Precursor Adult Acute Lymphoblastic Leukemia Carrying TP53 Molecular Alterations. Genes 11 (9) (2020)
Renato Bassan, Chiara Pavoni, Tamara Intermesoli, Orietta Spinelli, Manuela Tosi, Ernesta Audisio, Filippo Marmont, Chiara Cattaneo, Erika Borlenghi, Sergio Cortelazzo, Irene Cavattoni, Monica Fumagalli, Daniele Mattei, Claudio Romani, Agostino Cortelezzi, Nicola Fracchiolla, Fabio Ciceri, Bernardi Massimo, Anna Maria Scattolin, Lorella Depaoli, Arianna Masciulli, Elena Oldani, Alessandro Rambaldi
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18-65 years: NILG ALL 10/07. Blood cancer journal 10 (11) (2020)
Renato Bassan, Monica Fumagalli, Sabina Chiaretti, Ernesta Audisio, Nicola Cascavilla, Stefania Paolini, Mario Delia, Elisa Cerqui, Caterina Micò, Francesco Fabbiano, Martina Canichella, Anna Maria Scattolin, Paola Perfetti, Francesca Paoloni, Mariangela Iodice, Antonella Vitale, Irene Della Starza, Paola Fazi, Marco Vignetti, Robin Foà
Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocol. Leukemia & lymphoma 60 (14) (2019)